Cite
Serum peroxiredoxin-4, a biomarker of oxidative stress, is associated with the development of nephropathy in patients with type 2 diabetes (Zodiac-65).
MLA
Bourgonje, Arno R., et al. “Serum Peroxiredoxin-4, a Biomarker of Oxidative Stress, Is Associated with the Development of Nephropathy in Patients with Type 2 Diabetes (Zodiac-65).” Free Radical Biology & Medicine, vol. 212, Feb. 2024, pp. 186–90. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2023.12.025.
APA
Bourgonje, A. R., van Goor, H., Bakker, S. J. L., Hillebrands, J.-L., Bilo, H. J. G., Dullaart, R. P. F., & van Dijk, P. R. (2024). Serum peroxiredoxin-4, a biomarker of oxidative stress, is associated with the development of nephropathy in patients with type 2 diabetes (Zodiac-65). Free Radical Biology & Medicine, 212, 186–190. https://doi.org/10.1016/j.freeradbiomed.2023.12.025
Chicago
Bourgonje, Arno R., Harry van Goor, Stephan J.L. Bakker, Jan-Luuk Hillebrands, Henk J.G. Bilo, Robin P.F. Dullaart, and Peter R. van Dijk. 2024. “Serum Peroxiredoxin-4, a Biomarker of Oxidative Stress, Is Associated with the Development of Nephropathy in Patients with Type 2 Diabetes (Zodiac-65).” Free Radical Biology & Medicine 212 (February): 186–90. doi:10.1016/j.freeradbiomed.2023.12.025.